Emily Conley

Biotech executive and CEO of Renasant (Renaissance) Bio focused on developing small-molecule correctors and potentiators for autosomal-dominant polycystic kidney disease (ADPKD), with prior leadership experience at 23andMe and as CEO of Federation Bio.

Best podcasts with Emily Conley

Ranked by the Snipd community

14 snips

Dec 15, 2025 • 1h 8min

Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease

Emily Conley, CEO of Renasant Bio, discusses groundbreaking approaches to autosomal-dominant polycystic kidney disease (ADPKD). She shares her journey from caregiving and early scientific pursuits to executive roles at 23andMe and Federation Bio. Emily explains the potential of small molecules to correct genetic mutations in ADPKD and the hope for early interventions. She highlights the importance of targeting polycystins and the exciting developments on the horizon for kidney disease research.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app